Clinical trials for Hepatitis delta
34 recruiting or active trials synced from ClinicalTrials.gov.
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data- RECRUITINGPHASE2, PHASE3NCT07454837Phase 2b/3 Study to Evaluate Switching to Brelovitug for the Treatment of CHD in Participants Receiving BulevirtideMirum Pharmaceuticals, Inc.
- RECRUITINGNCT07491848Oral-Periodontal Evaluation and Assessment of Oral Fluid Biomarkers in Patients With Hepatitis B+DResearch Center of Periodontal-Systemic Interactions
- RECRUITINGPhase 3NCT07298330A Trial Evaluating Brelovitug vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta Infection (AZURE-4)Mirum Pharmaceuticals, Inc.
- RECRUITINGNCT07317011"Referral Attivo" Delta, Dallo Screening Alla Presa in Carico.FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS · PI: Eleonora Sfreddo
- RECRUITINGNCT07429864Changes in Bile Acids and Microbiota in Patients With Hepatitis D Treated With BulvertideFondazione Policlinico Universitario Agostino Gemelli IRCCS · PI: Francesca Romana Ponziani
- RECRUITINGPhase 3NCT07200908A Trial Evaluating Brelovitug (BJT-778) vs Bulevirtide for the Treatment of Chronic Hepatitis Delta Infection (AZURE-2)Mirum Pharmaceuticals, Inc.
- ACTIVE NOT RECRUITINGPhase 2NCT07142811A Study to Evaluate Tobevibart+Elebsiran Versus Bulevirtide in Chronic HDV InfectionVir Biotechnology, Inc.
- RECRUITINGPHASE1, PHASE2NCT07096193Study of GS-4321 in Healthy Participants and Participants With Chronic Hepatitis Delta VirusGilead Sciences · PI: Gilead Study Director
- RECRUITINGPhase 3NCT07128550A Study to Evaluate Tobevibart+Elebsiran in Participants With Chronic HDV Infection Not Virologically Suppressed With BulevirtideVir Biotechnology, Inc.
- RECRUITINGNCT07442760ePro Diary - HDV ( MACROLIVER )FROM- Fondazione per la Ricerca Ospedale di Bergamo- ETS
- ACTIVE NOT RECRUITINGPHASE2, PHASE3NCT06907290A Trial Evaluating BJT-778 vs Delayed Treatment for the Treatment of Chronic Hepatitis Delta InfectionMirum Pharmaceuticals, Inc.
- ACTIVE NOT RECRUITINGPhase 3NCT06903338A Study to Evaluate Tobevibart + Elebsiran in Chronic HDV InfectionVir Biotechnology, Inc.
- RECRUITINGNCT06889805HDV Screening StudyGrace Lai Hung Wong · PI: Lai Hung Grace Wong
- ACTIVE NOT RECRUITINGPhase 2NCT06505928A Clinical Trial of Hepalatide for Injection in Patients With Chronic Hepatitis DShanghai HEP Pharmaceutical Co., Ltd. · PI: Oyunbileg Janchiv
- ACTIVE NOT RECRUITINGNCT06638320Hepatitis Delta Virus Infection: Cross-sectional Study in Patients With Chronic Hepatitis B Virus InfectionTam Anh Research Institute
- ACTIVE NOT RECRUITINGN/ANCT06603311Finite Treatment of Hepatitis Delta With Bulevirtide: Identification of Biomarkers Associated With Sustained Control of HDV InfectionHannover Medical School
- RECRUITINGNCT06504485Immunological and Virological Characterization of Patients With Chronic HBV-HDV Infection: Outcomes and Response to Bulevirtide TreatmentFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- ACTIVE NOT RECRUITINGPhase 2NCT06649266Trial to Evaluate the Efficacy, Safety and Pharmacokinetics of RBD1016 in Participants With Chronic Hepatitis DRibocure Pharmaceuticals AB
- RECRUITINGNCT06397859Effectiveness and Clinical Outcomes of Long-term Bulevirtide Monotherapy in Patients With HDV-related Compensated CirrhosisFondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- RECRUITINGNCT06264583HDV-Europe: Prevalence and Outcome of HDV in HIV/HBV CoinfectionUniversity Hospital, Bonn · PI: Jürgen Rockstroh, MD
- RECRUITINGNCT06248580Find HDV and Determine Its Status in TurkeyYaşar Bayındır, MD · PI: Mustafa Kemal Çelen, MD
- RECRUITINGNCT05903742Standardising Care for Hepatitis Delta in the NetherlandsErasmus Medical Center
- RECRUITINGNCT05936073DELTA DESCRIBE: the French Collaborative ProjectUniversity Hospital, Limoges · PI: Véronique Loustaud-Ratti, Pr
- RECRUITINGNCT06051045Study to Evaluate Efficacy, Safety and Biomarkers of Bulevirtide Treatment in Chronic Hepatitis D PatientsKarolinska University Hospital
- RECRUITINGNCT06122285Effectiveness and Safety of Bulevirtide (BLV) Therapy in Patients With Chronic Hepatitis Delta (CHD) in Italy (D-SHIELD)Fondazione IRCCS Ca' Granda, Ospedale Maggiore Policlinico
- RECRUITINGNCT06160635D-SOLVE Cohorts (Cohort a and B)Hannover Medical School · PI: Markus Cornberg
- ACTIVE NOT RECRUITINGNCT05718700Study of Bulevirtide in Participants With Chronic Hepatitis D InfectionGilead Sciences · PI: Gilead Study Director
- RECRUITINGNCT05350865Thailand HDV CohortThe HIV Netherlands Australia Thailand Research Collaboration · PI: Anchalee Avihingsanon, MD, PhD
- ACTIVE NOT RECRUITINGPhase 2NCT05461170SOLSTICE: Combination Therapy for the Treatment of Chronic Hepatitis D Infection.Vir Biotechnology, Inc.
- ACTIVE NOT RECRUITINGNCT04863703Improvement of Portal Hypertension During Viral Suppression in Patients With Hepatitis Delta (IMPHROVE-D)Hannover Medical School · PI: Benjamin Maasoumy, MD
- RECRUITINGNCT04690972"Constitution of a Biological Collection to Establish Preclinical Translational Models for the Study of Tumors and Chronic Liver Diseases".Institut National de la Santé Et de la Recherche Médicale, France
- RECRUITINGNCT04166266National Cohort of Patients Co-infected With Hepatitis B and Delta VirusesANRS, Emerging Infectious Diseases · PI: Fabien ZOULIM
- ACTIVE NOT RECRUITINGNCT02344680Liver Fibrosis in Zambian HIV-HBV Co-infected PatientsUniversity of Alabama at Birmingham · PI: Michael J Vinikoor, MD
- RECRUITINGNCT00001971Evaluation of Patients With Liver DiseaseNational Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) · PI: T. Jake Liang, M.D.